Liquid biopsy and minimal residual disease — latest advances and implications for cure K Pantel, Nat Rev Clin Oncology, February 22, 2019

Main|Search|PHGKB


Last Posted: Feb 22, 2019

---

• Liquid biopsy and minimal residual disease — latest advances and implications for cure
  K Pantel, Nat Rev Clin Oncology, February 22, 2019
• Evolution of the genomic landscape of circulating tumor DNA (ctDNA) in metastatic prostate cancer over treatment and time.
  Hahn Andrew W et al. Cancer treatment and research communications 2019 Feb 19100120
• Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metastases.
  Seoane J et al. Annals of oncology : official journal of the European Society for Medical Oncology 2018 Dec
• Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic.
  Ghatalia Pooja et al. Frontiers in oncology 2018 8652
• Overview of the genetic basis toward early detection of breast cancer.
  De Silva Sumadee et al. Breast cancer (Dove Medical Press) 2019 1171-80
• A multicenter single-arm Phase II clinical trial of second-line FOLFIRI plus panitumumab after first-line treatment with FOLFOX plus panitumumab for initial RAS wild-type colorectal cancer with evaluation of circulating tumor DNA: A protocol study.
  Maeda Hiromichi et al. Oncology letters 2019 Feb 17(2) 1980-1985
• Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time?
  Buono Giuseppe et al. Cancer treatment reviews 2019 Jan 7373-83
• Brief Report: Clinical Utility of Cerebrospinal Fluid Cell Free-DNA as Liquid Biopsy for Leptomeningeal Metastases in ALK-Rearranged NSCLC.
  Zheng Mei-Mei et al. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2019 Jan
• Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy.
  Gai Wanxia et al. Genes 2019 Jan 10(1)
• Urinary proteomics and precision medicine for chronic kidney disease: Current status and future perspectives.
  Persson Frederik et al. Proteomics. Clinical applications 2019 Jan e1800176

more